chr20-46560194-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022829.6(SLC13A3):c.1637G>A(p.Arg546Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000169 in 1,614,010 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R546W) has been classified as Uncertain significance.
Frequency
Consequence
NM_022829.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC13A3 | NM_022829.6 | c.1637G>A | p.Arg546Gln | missense_variant | 13/13 | ENST00000279027.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC13A3 | ENST00000279027.9 | c.1637G>A | p.Arg546Gln | missense_variant | 13/13 | 1 | NM_022829.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152126Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000157 AC: 39AN: 248184Hom.: 0 AF XY: 0.000201 AC XY: 27AN XY: 134312
GnomAD4 exome AF: 0.000172 AC: 251AN: 1461766Hom.: 0 Cov.: 31 AF XY: 0.000172 AC XY: 125AN XY: 727192
GnomAD4 genome AF: 0.000145 AC: 22AN: 152244Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74440
ClinVar
Submissions by phenotype
Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 09, 2020 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 08, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SLC13A3 protein function. ClinVar contains an entry for this variant (Variation ID: 161765). This variant has not been reported in the literature in individuals affected with SLC13A3-related conditions. This variant is present in population databases (rs188700676, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 546 of the SLC13A3 protein (p.Arg546Gln). - |
Malignant tumor of prostate Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Science for Life laboratory, Karolinska Institutet | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at